CN102088962B - 用于皮质类固醇口服给药的组合物 - Google Patents

用于皮质类固醇口服给药的组合物 Download PDF

Info

Publication number
CN102088962B
CN102088962B CN2009801272725A CN200980127272A CN102088962B CN 102088962 B CN102088962 B CN 102088962B CN 2009801272725 A CN2009801272725 A CN 2009801272725A CN 200980127272 A CN200980127272 A CN 200980127272A CN 102088962 B CN102088962 B CN 102088962B
Authority
CN
China
Prior art keywords
release component
drug
sustained release
composition according
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009801272725A
Other languages
English (en)
Chinese (zh)
Other versions
CN102088962A (zh
Inventor
皮特·沃茨
A·M·迪俄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Famanik Co
Kalititas Treatment Co
Xiehe Qilin Service Co ltd
Kyowa Kirin Services Ltd
Original Assignee
Archimedes Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39571149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102088962(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Archimedes Development Ltd filed Critical Archimedes Development Ltd
Publication of CN102088962A publication Critical patent/CN102088962A/zh
Application granted granted Critical
Publication of CN102088962B publication Critical patent/CN102088962B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2009801272725A 2008-05-12 2009-05-07 用于皮质类固醇口服给药的组合物 Active CN102088962B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0808537.5A GB0808537D0 (en) 2008-05-12 2008-05-12 Compositions
GB0808537.5 2008-05-12
PCT/GB2009/001150 WO2009138716A1 (en) 2008-05-12 2009-05-07 Compositions for the oral delivery of corticosteroids

Publications (2)

Publication Number Publication Date
CN102088962A CN102088962A (zh) 2011-06-08
CN102088962B true CN102088962B (zh) 2013-07-31

Family

ID=39571149

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801272725A Active CN102088962B (zh) 2008-05-12 2009-05-07 用于皮质类固醇口服给药的组合物

Country Status (9)

Country Link
US (1) US8491932B2 (https=)
EP (1) EP2278958B1 (https=)
JP (1) JP5608641B2 (https=)
CN (1) CN102088962B (https=)
DK (1) DK2278958T3 (https=)
ES (1) ES2452265T3 (https=)
GB (1) GB0808537D0 (https=)
PL (1) PL2278958T3 (https=)
WO (1) WO2009138716A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2419443C1 (ru) * 2009-12-08 2011-05-27 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ лечения больных язвенным колитом
PL2659881T3 (pl) 2012-04-30 2018-05-30 Tillotts Pharma Ag Formulacja leku o opóźnionym uwalnianiu
JP6273356B2 (ja) 2013-10-29 2018-01-31 ティロッツ・ファルマ・アクチエンゲゼルシャフトＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 遅延放出性薬物製剤
CN104257669A (zh) * 2014-09-25 2015-01-07 合肥平光制药有限公司 一种用于向肠道递送水杨酸类药物的口服给药组合物
EP3346996A4 (en) 2015-09-11 2019-04-17 Sun Pharmaceutical Industries Limited ORAL PHARMACEUTICAL PHARMACEUTICAL FORM OF BUDESONID
EP3257501A1 (en) * 2016-06-14 2017-12-20 Tillotts Pharma AG Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
EP3554346B1 (en) 2016-12-14 2024-01-31 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
WO2018111329A1 (en) * 2016-12-14 2018-06-21 Progenity Inc. Methods and ingestible devices for the regio-specific release of il-1 inhibitors at the site of gastrointestinal tract disease
JP7125436B2 (ja) * 2017-06-23 2022-08-24 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド 乱用抑止経口固体投与形態
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
CN110200947A (zh) * 2019-06-27 2019-09-06 深圳市泛谷药业股份有限公司 一种安非他酮肠溶缓释微丸胶囊及其制备方法
CN112999229B (zh) * 2019-12-19 2023-01-24 江苏恒瑞医药股份有限公司 一种包含布地奈德的口服药物组合物
CA3216303A1 (en) 2021-04-20 2022-10-27 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Capsule for specific drug delivery and preparation method therefor
TW202302116A (zh) * 2021-04-20 2023-01-16 大陸商江蘇恒瑞醫藥股份有限公司 口服腸溶皮質類固醇的藥物組合物
US11896719B2 (en) * 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
EP4554566A1 (en) 2022-07-15 2025-05-21 Synthon B.V. Budesonide two layers capsule formulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914122A (en) * 1994-12-27 1999-06-22 Dr. Falk Pharma Gmbh Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123403A (en) * 1977-06-27 1978-10-31 The Dow Chemical Company Continuous process for preparing aqueous polymer microsuspensions
US4502888A (en) * 1982-12-13 1985-03-05 The Dow Chemical Company Aqueous dispersions of plasticized polymer particles
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5142906A (en) * 1990-07-09 1992-09-01 Westinghouse Electric Corp. Apparatus for measuring valve stem loads in a motor operated valve assembly
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
GB9722426D0 (en) * 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
US6239120B1 (en) * 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
ITRM20010614A1 (it) 2001-10-16 2003-04-16 Italchimici S P A Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.
JP2003201256A (ja) * 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
DE10214002A1 (de) 2002-03-27 2003-10-09 Roehm Gmbh Pharmazeutische Formulierung für den Wirkstoff Budesonid
AR041873A1 (es) 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
KR20100121601A (ko) * 2007-12-17 2010-11-18 콤비네이토릭스, 인코포레이티드 면역염증성 질환의 치료를 위한 치료요법

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914122A (en) * 1994-12-27 1999-06-22 Dr. Falk Pharma Gmbh Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
唐星.乙基纤维素.《口服缓控释制剂》.人民卫生出版社,2007,(第1版), *

Also Published As

Publication number Publication date
HK1158510A1 (en) 2012-07-20
GB0808537D0 (en) 2008-06-18
DK2278958T3 (da) 2014-01-20
US20110104269A1 (en) 2011-05-05
JP5608641B2 (ja) 2014-10-15
EP2278958B1 (en) 2014-01-01
PL2278958T3 (pl) 2014-05-30
CN102088962A (zh) 2011-06-08
JP2011519967A (ja) 2011-07-14
WO2009138716A1 (en) 2009-11-19
US8491932B2 (en) 2013-07-23
EP2278958A1 (en) 2011-02-02
ES2452265T3 (es) 2014-03-31

Similar Documents

Publication Publication Date Title
CN102088962B (zh) 用于皮质类固醇口服给药的组合物
KR101157220B1 (ko) 리팍시민을 포함하는 위내성 약학적 제제
JPH0759499B2 (ja) 拡散被覆された複合単位服用剤
JPH0759500B2 (ja) 拡散被覆された複合単位服用剤
CN101677958A (zh) 用于结肠-特异性递送的口服药物制剂
JP2011500553A (ja) ５−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤
JP2005521682A (ja) 結腸放出組成物
TW201742621A (zh) 包含經黏膜黏附性材料包覆之個別核心單元之核心及核心腸衣之多單元劑型
AU2025220793A1 (en) Delayed release drug formulation comprising an outer layer with an enzymatically degradable polymer, its composition and its method of manufacturing
CN112999229B (zh) 一种包含布地奈德的口服药物组合物
JP3469926B2 (ja) 大腸内放出型医薬製剤用粒状物
CN117157079A (zh) 一种口服肠溶皮质类固醇的药物组合物
WO2001070221A1 (en) Sustained release oral preparations
HK1158510B (en) Compositions for the oral delivery of corticosteroids
WO2026003735A1 (en) Oral platform for site-specific release to the colon
CN119745838A (zh) 一种不含碱的用于肠道递送皮质类固醇药物的口服给药组合物
HK40031885B (en) Delayed release drug formulation comprising an outerlayer with an enzymatically degradable polymer, its composition and its method of manufacturing
EA050069B1 (ru) Лекарственный препарат с отсроченным высвобождением, содержащий внешний слой с ферментативно разлагаемым полимером, его состав и способ его получения
EA043403B1 (ru) Пеллета с многослойной структурой для замедленного высвобождения действующего вещества в дистальный отдел толстой кишки

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1158510

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1158510

Country of ref document: HK

CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: London

Patentee after: Xiehe Qilin Service Co.,Ltd.

Patentee after: Kalititas Treatment Co.

Address before: Nottingham, England

Patentee before: ARCHIMEDES DEVELOPMENT LTD.

Patentee before: Famanik Co.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20231115

Address after: Nottingham, England

Patentee after: ARCHIMEDES DEVELOPMENT LTD.

Patentee after: Famanik Co.

Address before: Nottingham, England

Patentee before: ARCHIMEDES DEVELOPMENT LTD.